01 May 2004
Quality and safety of organ transplantation.
Kaija SalmelaAnn Transplant 2004; 9(1): 51-52 :: ID: 142792
Abstract
Transplantation, like all medical procedures, carries potential risks forboth donors, recipients and health care personnel. Living donation and associated morbidity and mortalityare documented in living donor registries which, run nationally, are a step toward long-term qualitycontrol in organ transplantation. Such quality control and management should however be a part of allstages of the transplantation process, beginning with donor identification and ending with long-termfollow up of transplant recipients. A whole range of transplantation-related events would be controlled,including organ procurement, handling, risk of disease/malignancy transmission, recipient operation andfollow up. Several international bodies and institutions have formulated statements addressing theseissues. The essential ideas of these documents are focused on protection of human integrity, avoidanceof bodily harm and coercion, exclusion of commercialism, equitable access to transplantation, fairnessof allocation, transparency of the allocation criteria/procedures, competence requirements of the staffand quality management.
In Press
Original article
Common Versus External Iliac Arterial Anastomosis in Kidney Transplantation: A Bicentric Retrospective Anal...Ann Transplant In Press; DOI: 10.12659/AOT.953269
Original article
Protective Effects of Quercetin and Sucrose on Cold Preservation Injury in Porcine Kidneys Donated After Ca...Ann Transplant In Press; DOI: 10.12659/AOT.952503
Original article
Four Years of Clinical Experience With COVID-19 Outcomes in Heart Transplant RecipientsAnn Transplant In Press; DOI: 10.12659/AOT.952888
Original article
Determinants of Lack of Consent for Deceased Organ Donation Among Nurses and Physicians: A Cross-Sectional ...Ann Transplant In Press; DOI: 10.12659/AOT.953598
Most Viewed Current Articles
24 Aug 2021 : Review article 21,160
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article 17,335
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
22 Nov 2022 : Original article 16,325
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
05 Apr 2022 : Original article 16,249
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604






